A 47-year-old Vietnamese man died suddenly after, trusting advice found on social media, he stopped taking blood pressure ...

Linda Pescatello, Board of Trustees Distinguished Professor in the Department of Kinesiology (CAHNR), has established herself ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Primary hypertension, the most common type, has no known cause, but ...

Researchers at Yale School of Medicine (YSM) examined two known risk factors for developing dementia—one genetic and one ...

The investigational aldosterone synthase inhibitor lorundrostat demonstrated efficacy in reducing systolic blood pressure and albuminuria for patients with uncontrolled hypertension and chronic kidney ...

Some fats are harmful and can make your blood pressure worse. One of the worst types is trans fats. These are artificial fats ...

Lowering systolic blood pressure is linked to a similar reduction in the risk for major cardiovascular events in people with ...

The burden of cardiovascular-kidney-metabolic (CKM) comorbidities among adults with gout is high, noted Chio Yokose, MD, MSc, ...

By improving BP control and treatment adherence, use of fixed-dose combination therapies is expected to drive down CV events ...

NDA submissions for NCX 470 are planned for the first half of 2026 in the US, with China following shortly after. NCX 470 is ...

Despite high costs, millions of Americans are uninsured or underinsured, leading to untreated conditions like hypertension.